Results 331 to 340 of about 8,570,567 (357)
Empagliflozin combined with bortezomib in the treatment of heavy and light chain amyloidosis with secondary diabetes: A case report. [PDF]
Zhang N +5 more
europepmc +1 more source
Impact of Light-Chain Variants on the Expression of Therapeutic Monoclonal Antibodies in HEK293 and CHO Cells. [PDF]
Veber A +9 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis
Journal of Neurology Neurosurgery & Psychiatry, 2018Objective To determine the diagnostic and prognostic performance of serum neurofilament light chain (NFL) in amyotrophic lateral sclerosis (ALS). Methods This single-centre, prospective, longitudinal study included the following patients: 124 patients ...
F. Verde +17 more
semanticscholar +1 more source
Systemic immunoglobulin light chain amyloidosis
Nature Reviews Disease Primers, 2018G. Merlini +6 more
semanticscholar +1 more source
Planning for post‐pandemic cancer care delivery: Recovery or opportunity for redesign?
Ca-A Cancer Journal for Clinicians, 2021Pelin Cinar +2 more
exaly
A roadmap for the commercialization of perovskite light emitters
Nature Reviews Materials, 2022, Richard Friend, Edward H Sargent
exaly
Visible Light-Driven Radical-Mediated C–C Bond Cleavage/Functionalization in Organic Synthesis
Chemical Reviews, 2021Jia-Rong Chen, Wen-Jing Xiao
exaly

